C4 Imaging

C4 Imaging develops innovative medical devices
that enable clinicians to personalize patient
treatment through accurate image-guided
procedures.

The company’s core proprietary
technology, C4, is a unique magnetic resonance
imaging (MRI) agent that has been encapsulated
within an implantable, biocompatible shell.
C4 Imaging’s first product is the Sirius™ MRI Marker,
which will be used to facilitate seed localization
during the treatment of prostate cancer.

The Sirius™ MRI Marker will allow physicians to
accurately locate seeds within the complicated anatomy
of the prostate and the surrounding critical structures,
utilizing a single post-implant MR imaging procedure.

C4 Imaging’s goal is to improve quality assurance by
allowing post-implant seed localization to be performed
with MRI alone, eliminating the need for computed
tomography in assessment of prostate brachytherapy.

Company’s Keywords: